What gene therapies are approved?
Category:
medical health
cancer
(A) In vivo approved gene therapy drugs such as Neovasculgen, Glybera, Defitelio, Rexin-G, Onpattro, Eteplirsen, Spinraza, Kynamro, Imlygic, Oncorine, Luxturna, Macugen, Gendicine, Vitravene as well as Zolgensma directly injected into their target tissue or organ.
Simply so, are there any approved gene therapies?
The U.S. Food and Drug Administration (FDA) has approved only a limited number of gene therapy products for sale in the United States. Hundreds of research studies (clinical trials) are under way to test gene therapy as a treatment for genetic conditions, cancer, and HIV/AIDS.
Likewise, how many gene therapies are approved?
At least nine gene therapies have been approved for certain kinds of cancer, some viral infections and a few inherited disorders.
In December, the FDA approved Luxturna, the first in vivo gene therapy, for the treatment of blindness due to Leber's congenital amaurosis.